Multiomic Analysis of Real-World Data for Reverse Translation Across Fibrotic Diseases
Time: 2:00 pm
day: Day One
Details:
- Examine how large-scale patient data sets can inform early-stage drug discovery and how to leverage these patient data sets to identify potential causative targets
- Highlighting the importance of incorporating primary clinical trial endpoints and fibrosis measurements to increase the probability of anti-fibrotic and clinical efficacy in patients
